Dec 4, 2024
8:30am - 8:45am
Hynes, Level 3, Room 313
Eric DuBois1,Kate Herrema1,Matthew Simkulet1,Laboni Hassan1,Payton O'Connor2,1,Riya Sen3,1,Timothy O'Shea1
Boston University1,Rensselaer Polytechnic Institute2,Georgia Institute of Technology and Emory University3
Eric DuBois1,Kate Herrema1,Matthew Simkulet1,Laboni Hassan1,Payton O'Connor2,1,Riya Sen3,1,Timothy O'Shea1
Boston University1,Rensselaer Polytechnic Institute2,Georgia Institute of Technology and Emory University3
Implantable medical devices, such as subcutaneous drug delivery systems or deep brain stimulation electrodes, are powerful tools for disease treatment. However, implantation of these devices stimulates a multicellular foreign body response (FBR) leading to device encapsulation by fibrotic tissue, which attenuates device function. Biomaterial coatings, which adhere or bond to the device surface, or biomaterial films, which can be press-fit as a separate material layer onto devices, hold promise for both preventing premature failure of chronically implanted medical devices and enhancing the device functionality and performance. However, current hydrophilic polymers used in device coatings and films have significant drawbacks such as swelling and delamination. In this work, we address these limitations by developing an oxidation-responsive, bio-inspired polymer (HEC<sub>MTP</sub>) which is synthesized by modifying hydroxyethyl cellulose (HEC), with 3-(methylthio)-propyl isothiocyanate (MTPI). HEC<sub>MTP</sub> readily dissolves in dimethyl sulfoxide (DMSO) and blends of other green solvents. By tuning polymer solution viscosity through solvent and concentration selection, HEC<sub>MTP</sub> can be controllably deposited onto substrates to create coatings between 1-30µm in thickness or drop cast to form free standing, smooth and transparent films ranging from 7-70µm in thickness. When HEC<sub>MTP</sub>-coated substrates are exposed to physiologically relevant concentrations (40-80µM) of reactive oxygen species (ROS) <i>in vitro</i>, thioether moieties on the HEC<sub>MTP</sub> are oxidized to sulfoxide groups, resulting in a significant increase in hydrophilicity and softening of the coating interface, as well as a >92% decrease in cell biofouling <i>in vitro</i>. HEC<sub>MTP</sub> coatings show a strong resistance to delamination, a capacity for oxidation-responsive and controlled release of small molecules and biomacromolecules, and exceptional optical transparency. Subcutaneous implantation of HEC<sub>MTP</sub> resulted in a significant decrease in remodeled tissue thickness relative to similarly functionalized, non-oxidation responsive, HEC-derived materials. These results highlight the wide utility of HEC<sub>MTP</sub> and support its use as a coating for implanted medical devices to enhance device efficacy and longevity.